UroGen Pharma (URGN) Other Working Capital Changes (2018 - 2026)
UroGen Pharma (URGN) posted Other Working Capital Changes of -$53000.0 for Q1 2026, down 103.98% on a QoQ basis from $1.3 million in Q4 2025, and up 92.82% year-over-year from -$27487.0 in Q1 2025.
UroGen Pharma (URGN) Other Working Capital Changes (2018 - 2026) Analysis & Trends
UroGen Pharma's Other Working Capital Changes history runs 6 years deep, the most recent figure standing at -$53000.0 for Q1 2026.
- Quarterly Other Working Capital Changes rose 92.82% year-over-year to -$53000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46000.0 (up 103.02% YoY) and the FY2025 annual result came in at -$639000.0, up 38.2% from the prior year.
- Other Working Capital Changes was -$53000.0 for Q1 2026 at UroGen Pharma, down from $1.3 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.9 million in Q1 2026 and bottomed at -$5.8 million in Q4 2023.
- A 5-year average of $709117.6 and a median of $1.0 million in 2023 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 426.72% in 2025, while the deepest fall reached 241.3% in 2025.
- UroGen Pharma's Other Working Capital Changes stood at -$269000.0 in 2022, then increased by 17.84% to -$221000.0 in 2023, then plunged by 84.62% to -$408000.0 in 2024, then jumped by 426.72% to $1.3 million in 2025, then plunged by 103.98% to -$53000.0 in 2026.
- Business Quant data shows URGN's Other Working Capital Changes at -$53000.0 in Q1 2026, $1.3 million in Q4 2025, and -$628000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | UroGen Pharma | 2.05 Bn | 1.91 Bn | 46.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.86 Mn |
| Mar 31, 2026 | 4.86 Mn |
| Mar 31, 2026 | 4.86 Mn |
| Dec 31, 2025 | 2.55 Mn |
| Dec 31, 2025 | 2.55 Mn |
| Dec 31, 2025 | 2.55 Mn |
| Sep 30, 2025 | 67,000.00 |
| Sep 30, 2025 | 67,000.00 |
| Sep 30, 2025 | 67,000.00 |
| Jun 30, 2025 | -928,000.00 |
| Jun 30, 2025 | -928,000.00 |
| Jun 30, 2025 | -928,000.00 |
| Mar 31, 2025 | 4.14 Mn |
| Mar 31, 2025 | 4.14 Mn |
| Mar 31, 2025 | 4.14 Mn |
| Dec 31, 2024 | -5.21 Mn |
| Dec 31, 2024 | -5.21 Mn |
| Dec 31, 2024 | -5.21 Mn |
| Sep 30, 2024 | 1.85 Mn |
| Sep 30, 2024 | 1.85 Mn |